# Commission Regulation (EU) No 957/2010 of 22 October 2010 on the authorisation and refusal of authorisation of certain health claims made on foods and referring to the reduction of disease risk and to children’s development and health (Text with EEA relevance), Annex II

Extent: E+W+S+N.I.

Rejected health claims
Application — Relevant provisions of Regulation (EC) No 1924/2006
Nutrient, substance, food or food category
Claim
EFSA opinion reference
Article 14(1)(a) health claim referring to a reduction of a disease risk
OPC Premium™
OPC have been shown to reduce blood cholesterol levels and may therefore reduce the risk of cardiovascular disease
Q-2009-00454
Article 14(1)(a) health claim referring to a reduction of a disease risk
Uroval®
Cranberry extract and D-mannose, the main active ingredients of the food supplement Uroval®, eliminate the adhesion of harmful bacteria to the bladder wall. The adhesion of harmful bacteria to the bladder wall is the main risk factor in the development of urinary tract infections
Q-2009-00600
Article 14(1)(b) health claim referring to children’s development and health
Combination of bifidobacteria (Bifidobacterium bifidum, Bifidobacterium breve, Bifidobacterium infantis, Bifidobacterium longum)
Probiotic bifidobacteria lead to a healthy intestinal flora comparable to the composition of the intestinal flora of breast-fed infants’ intestine
Q-2009-00224

---
Source: https://www.legislation.gov.uk/eur/2010/957/annex/II (the official version)
Page: https://openlegislation.uk/eu-regulation-2010-957/annex-II
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.